These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35494328)

  • 1. Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence.
    Ghosh A; Mahintamani T; Rana DK; Basu D; Mattoo SK
    Indian J Psychiatry; 2022; 64(2):199-208. PubMed ID: 35494328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: A comparative study with three matched control groups.
    Saroj R; Ghosh A; Subodh BN; Nehra R; Mahintamani T; Rana DK; Basu D
    Asian J Psychiatr; 2020 Oct; 53():102181. PubMed ID: 32526693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive Functions After 6-Month Buprenorphine (Naloxone)-Based Opioid Agonist Maintenance Treatment: A Controlled Prospective Study.
    Ghosh A; Shaktan A; Nehra R; Verma A; Rana DK; Ahuja CK; Modi M; Singh P; Basu D
    J Clin Psychopharmacol; 2024 Mar-Apr 01; 44(2):141-150. PubMed ID: 38421923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive Functions in Patients with Comorbid Hepatitis C and Opioid Dependence: A Comparative Study.
    Ghosh A; Mahintamani T; Rana DK; Basu D; Mattoo SK; Premkumar M; Singh GK
    Indian J Psychol Med; 2023 Mar; 45(2):146-154. PubMed ID: 36925501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Cannabis Dependence Add on to the Neurocognitive Impairment Among Patients With Opioid Dependence? A Cross-Sectional Comparative Study.
    Ghosh A; Basu D; Mattoo SK; Kumar Rana D; Roub F
    Am J Addict; 2020 Mar; 29(2):120-128. PubMed ID: 31951069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study.
    Ghosh A; Shaktan A; Verma A; Basu D; Rana DK; Nehra R; Ahuja CK; Modi M; Singh P
    J Psychoactive Drugs; 2024 Jan; ():1-13. PubMed ID: 38251910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin use and neuropsychological impairments: comparison of intravenous and inhalational use.
    Ghosh A; Shaktan A; Nehra R; Basu D; Verma A; Rana DK; Modi M; Ahuja CK
    Psychopharmacology (Berl); 2023 Apr; 240(4):909-920. PubMed ID: 36779990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial.
    Gunderson EW; Hjelmström P; Sumner M;
    Clin Ther; 2015 Oct; 37(10):2244-55. PubMed ID: 26412801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dysfunction in men on buprenorphine - naloxone-based substitution therapy.
    Mattoo SK; Ghosh A; Subodh BN; Basu D; Satapathy A; Prasad S; Sharma MP
    Indian J Psychiatry; 2020; 62(1):66-72. PubMed ID: 32001933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmaceutical properties of a novel buprenorphine/naloxone sublingual tablet for opioid substitution therapy versus conventional buprenorphine/naloxone sublingual tablet in healthy volunteers.
    Jönsson M; Mundin G; Sumner M
    Eur J Pharm Sci; 2018 Sep; 122():125-133. PubMed ID: 29940217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double-blind, within-subject, crossover study among opioid-dependent subjects.
    Dhagudu NK; Ambekar A; Agrawal A; Rao R; Mishra AK; Jain R; Singh S
    Drug Alcohol Rev; 2020 Jul; 39(5):595-603. PubMed ID: 32162420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
    Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
    Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of a Rapidly Dissolving Buprenorphine/Naloxone Sublingual Tablet (BNX-RDT) for Treatment of Opioid Dependence: A Multicenter, Open-label Extension Study.
    Hoffman K; Peyton ML; Sumner M
    J Addict Med; 2017; 11(3):217-223. PubMed ID: 28353467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive functioning in patients maintained on buprenorphine at peak and trough buprenorphine levels: An experimental study.
    Singh A; Rao R; Chatterjee B; Mishra AK; Kaloiya G; Ambekar A
    Asian J Psychiatr; 2021 Jul; 61():102697. PubMed ID: 34030027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
    Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
    Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision-making impairment on the Iowa Gambling Task after endovascular coiling or neurosurgical clipping for ruptured anterior communicating artery aneurysm.
    Escartin G; Junqué C; Juncadella M; Gabarrós A; de Miquel MA; Rubio F
    Neuropsychology; 2012 Mar; 26(2):172-80. PubMed ID: 22251310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of integrated buprenorphine/naloxone and HIV clinical care.
    Sullivan LE; Barry D; Moore BA; Chawarski MC; Tetrault JM; Pantalon MV; O'Connor PG; Schottenfeld RS; Fiellin DA
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S184-90. PubMed ID: 17109305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of psychological symptoms and cognitive functions in patients under maintenance treatment with methadone or buprenorphine, current opioid users and healthy subjects.
    Nikraftar NS; Feyzi YF; Ramzani F; Nikbakht-Zadeh M; Amini M; Arezoomandan M; Shiehmorteza M; Arezoomandan R
    Asian J Psychiatr; 2021 Apr; 58():102603. PubMed ID: 33621923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptual Knowledge Influences Decision Making Differently in Individuals with High or Low Cognitive Flexibility: An ERP Study.
    Dong X; Du X; Qi B
    PLoS One; 2016; 11(8):e0158875. PubMed ID: 27479484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.